Skip to main content
TipRanks
Go Ultimate75% OFF

Bactiguard Holding AB (0QV2) Share Price & Analysis

0 Followers

0QV2 Stock Chart & Stats

kr 15.00kr 0.00(0.00%)
At close: 4:30 PM GMT
kr 25kr 50kr 75kr 100Feb 1Aug 1Jan 25Oct 7Jan 9Aug 20
Day’s Range
SEK 15.00 - SEK 15.00
52-Week Range
SEK 15.00 - SEK 17.25
Previous Close
SEK 15.00
Volume
N/A
Average Volume (3M)
0
Market Cap
SEK 544.93M
Enterprise Value
SEK 648.89M
Total Cash (Recent Filing)
SEK 55.05M
Total Debt (Recent Filing)
SEK 153.75M
Price to Earnings (P/E)
86.4
Beta
0.11
Next Earnings
Feb 04, 2027 (Est.)
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improving Cash Generation

The return to positive operating and free cash flow strengthens internal funding capacity and reduces reliance on external financing. If maintained, better cash conversion can support product development, partner implementation, and regulatory activity while providing greater resilience through normal business fluctuations.

Moderate Leverage

Moderate and improving leverage, together with a sizable equity base, gives Bactiguard meaningful financial flexibility. This supports continued investment in its infection-prevention platform and partnerships while reducing the balance-sheet pressure that can constrain smaller medical-technology companies.

Proprietary Scalable Technology

Bactiguard’s proprietary coating platform can reach healthcare markets through manufacturer collaborations rather than relying only on direct product sales. Broader partner adoption could create scalable license and royalty opportunities while embedding infection-prevention technology into established device distribution channels.

Bears Say

Unproven Profitability

Despite substantial improvement from earlier losses, the company has not yet demonstrated durable operating profitability or positive shareholder returns. Continued losses could limit internally funded growth, weaken confidence in the business model, and make results more sensitive to execution and adoption timing.

Volatile Cash Conversion

The recent cash-flow improvement is encouraging, but large historical swings make it difficult to treat current generation as dependable. Inconsistent conversion can complicate investment planning and leave less certainty about the cash available for commercialization, partnerships, and ongoing operations.

Limited Revenue Momentum

Revenue growth remains relatively modest for a company seeking wider adoption of infection-prevention technology. Slower top-line expansion may delay operating leverage and the path to sustainable profit, particularly because commercialization depends on partner uptake, device sales, and healthcare procurement decisions.

Bactiguard Holding AB News

0QV2 FAQ

What was Bactiguard Holding AB’s price range in the past 12 months?
Bactiguard Holding AB lowest share price was kr 15.00 and its highest was kr 17.25 in the past 12 months.
What is Bactiguard Holding AB’s market cap?
Bactiguard Holding AB’s market cap is kr 544.93M.
When is Bactiguard Holding AB’s upcoming earnings report date?
Bactiguard Holding AB’s next earnings report is estimated for Feb 04, 2027 (not yet confirmed), which is in 77 days.
How were Bactiguard Holding AB’s earnings last quarter?
Bactiguard Holding AB released its earnings results on Oct 22, 2026. The company reported kr 0.3 earnings per share for the quarter, beating the consensus estimate of -kr 0.2 by kr 0.5.
Is Bactiguard Holding AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bactiguard Holding AB pay dividends?
Bactiguard Holding AB pays a dividend of kr 0.285 which represents an annual dividend yield of ―. See more information on Bactiguard Holding AB dividends here
What is Bactiguard Holding AB’s EPS estimate?
Bactiguard Holding AB’s EPS estimate is -0.10.
How many shares outstanding does Bactiguard Holding AB have?
Bactiguard Holding AB has 31,043,884 shares outstanding.
What happened to Bactiguard Holding AB’s price movement after its last earnings report?
Bactiguard Holding AB reported an EPS of kr 0.3 in its last earnings report, beating expectations of -kr 0.2. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bactiguard Holding AB?
Currently, no hedge funds are holding shares in GB:0QV2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology